Literature DB >> 17314161

Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Elena Priceputu1, Zaher Hanna, Chunyan Hu, Marie-Chantal Simard, Patrick Vincent, Steffen Wildum, Michael Schindler, Frank Kirchhoff, Paul Jolicoeur.   

Abstract

We previously reported that the human immunodeficiency virus type 1 NL4-3 Nef is necessary and sufficient to induce a severe AIDS-like disease in transgenic (Tg) mice when the protein is expressed under the regulatory sequences of the human CD4 gene. We have now assayed additional Nef alleles (SF2, JR-CSF, YU10x, and NL4-3 [T71R] Nef alleles), including some from long-term nonprogressors (AD-93, 032an, and 039nm alleles) in the same Tg system and compared their pathogenicities. All these Nef alleles downregulated cell surface CD4 in human cells in vitro and also, with the exception of Nef(YU10x), in Tg CD4(+) T cells. Depletion of double-positive and single-positive thymocytes occurred with all alleles but was less pronounced in Nef(YU10x) Tg mice. A loss of peripheral CD4(+) T cells was observed with all alleles but was minimal in Nef(YU10x) Tg mice. In Nef(032an) and Nef(SF2) Tg mice, T-cell loss was severe despite lower levels of Tg expression, suggesting a higher virulence of these alleles. All Nef alleles except the Nef(YU10x) and Nef(NL4-3(T71R)) alleles induced an enhanced activated memory (CD25(+) CD69(+) CD44(high) CD45RB(low) CD62L(low)) and apoptotic phenotype. Also, all could interact with and/or activate PAK2 except the Nef(JR-CSF) allele. Organ (lung and kidney) diseases were present in Nef(NL4-3(T71R)), Nef(032an), Nef(039nm), and Nef(SF2) Tg mice, despite very low levels of Tg expression for the last strain. However, no organ disease or minimal organ disease developed in Nef(YU10x) and Nef(AD-93) Tg mice and Nef(JR-CSF) Tg mice, respectively, despite high levels of Tg expression. Our data show that important differences in the pathogenicities of various Nef alleles can be scored in Tg mice. Interestingly, our results also revealed that some phenotypes can segregate independently, such as CD4(+) T-cell depletion and activation, as well as severe depletion of thymic CD4(+) T cells and peripheral CD4(+) T cells. Therefore, expression of Nef alleles in Tg mice under the CD4C regulatory elements represents a novel assay for measuring their pathogenicity. Because of the very high similarity of this murine AIDS-like disease to human AIDS, this assay may have a predictive value regarding the behavior of Nef in infected humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314161      PMCID: PMC1900134          DOI: 10.1128/JVI.02691-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  103 in total

1.  A novel mouse model of HIV-1 disease.

Authors:  P Jolicoeur; D G Kay; M Cool; S Jothy; N Rebai; Z Hanna
Journal:  Leukemia       Date:  1999-04       Impact factor: 11.528

2.  Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor.

Authors:  R Salvi; A R Garbuglia; A Di Caro; S Pulciani; F Montella; A Benedetto
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

Review 4.  The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors.

Authors:  V Piguet; O Schwartz; S Le Gall; D Trono
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

5.  Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

Authors:  J C Learmont; A F Geczy; J Mills; L J Ashton; C H Raynes-Greenow; R J Garsia; W B Dyer; L McIntyre; R B Oelrichs; D I Rhodes; N J Deacon; J S Sullivan
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

6.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice.

Authors:  Z Hanna; D G Kay; N Rebai; A Guimond; S Jothy; P Jolicoeur
Journal:  Cell       Date:  1998-10-16       Impact factor: 41.582

8.  Mice transgenic for simian immunodeficiency virus nef are immunologically compromised.

Authors:  N B Larsen; H W Kestler; J J Docherty
Journal:  J Biomed Sci       Date:  1998 Jul-Aug       Impact factor: 8.410

9.  Regions of human immunodeficiency virus type 1 nef required for function in vivo.

Authors:  G M Aldrovandi; L Gao; G Bristol; J A Zack
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease.

Authors:  F Kirchhoff; P J Easterbrook; N Douglas; M Troop; T C Greenough; J Weber; S Carl; J L Sullivan; R S Daniels
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

View more
  9 in total

Review 1.  Controversies in the pathogenesis of HIV-associated renal diseases.

Authors:  Leslie A Bruggeman; Peter J Nelson
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

2.  Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.

Authors:  Zaher Hanna; Elena Priceputu; Pavel Chrobak; Chunyan Hu; Véronique Dugas; Mathieu Goupil; Miriam Marquis; Louis de Repentigny; Paul Jolicoeur
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity.

Authors:  Susanne Rauch; Kati Pulkkinen; Kalle Saksela; Oliver T Fackler
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia.

Authors:  Mir Munir Ahmed Rahim; Pavel Chrobak; Chunyan Hu; Zaher Hanna; Paul Jolicoeur
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

5.  Nef is secreted in exosomes from Nef.GFP-expressing and HIV-1-infected human astrocytes.

Authors:  Pia Pužar Dominkuš; Jana Ferdin; Ana Plemenitaš; Boris Matija Peterlin; Metka Lenassi
Journal:  J Neurovirol       Date:  2017-07-31       Impact factor: 2.643

6.  Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2.

Authors:  Kevin C Olivieri; Joya Mukerji; Dana Gabuzda
Journal:  Retrovirology       Date:  2011-08-05       Impact factor: 4.602

7.  Inhibition of HIV-1 gene expression by Sam68 Delta C: multiple targets but a common mechanism?

Authors:  Alan Cochrane
Journal:  Retrovirology       Date:  2009-03-02       Impact factor: 4.602

8.  Compartmentalization of the gut viral reservoir in HIV-1 infected patients.

Authors:  Guido van Marle; M John Gill; Dione Kolodka; Leah McManus; Tannika Grant; Deirdre L Church
Journal:  Retrovirology       Date:  2007-12-04       Impact factor: 4.602

9.  HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era.

Authors:  Ceri Evans; Jean H Humphrey; Robert Ntozini; Andrew J Prendergast
Journal:  Front Immunol       Date:  2016-06-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.